As of 2025-05-18, the Intrinsic Value of Jiangsu Bioperfectus Technologies Co Ltd (688399.SS) is 13.36 CNY. This 688399.SS valuation is based on the model Discounted Cash Flows (EBITDA Exit 5Y). With the current market price of 69.59 CNY, the upside of Jiangsu Bioperfectus Technologies Co Ltd is -80.80%.
The range of the Intrinsic Value is 10.77 - 16.91 CNY
Based on its market price of 69.59 CNY and our intrinsic valuation, Jiangsu Bioperfectus Technologies Co Ltd (688399.SS) is overvalued by 80.80%.
| Range | Selected | Upside | |
| a | |||
| DCF (Growth 5y) | (69.74) - (18.87) | (29.88) | -142.9% |
| DCF (Growth 10y) | (21.85) - (73.86) | (33.22) | -147.7% |
| DCF (EBITDA 5y) | 10.77 - 16.91 | 13.36 | -80.8% |
| DCF (EBITDA 10y) | 20.26 - 37.78 | 27.46 | -60.5% |
| Fair Value | -12.90 - -12.90 | -12.90 | -118.54% |
| P/E | (10.72) - 3.90 | (4.21) | -106.0% |
| EV/EBITDA | (18.06) - 23.57 | 0.26 | -99.6% |
| EPV | 50.59 - 70.48 | 60.53 | -13.0% |
| DDM - Stable | (5.40) - (24.30) | (14.85) | -121.3% |
| DDM - Multi | 11.26 - 40.26 | 17.71 | -74.5% |
| Market Cap (mil) | 3,943.67 |
| Beta | 0.67 |
| Outstanding shares (mil) | 56.67 |
| Enterprise Value (mil) | 3,991.65 |
| Market risk premium | 6.13% |
| Cost of Equity | 8.30% |
| Cost of Debt | 5.00% |
| WACC | 8.07% |